Physician profile
John Lazar
NPI 1578756722
$79,404.59
in general payments reported to CMS, 2019-2025
25 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $9,362 · 2021: $1,076 · 2022: $31K · 2023: $1,446 · 2024: $4,034 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,296 · Travel and Lodging: $3,661 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,250 · Food and Beverage: $2,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,296.00 |
| Travel and Lodging | $3,660.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,250.00 |
| Food and Beverage | $2,377.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $36,199.16 | 2019-2022 | |
| Intuitive Surgical, INC. | $14,192.58 | 2019-2025 | Da Vinci Surgical System |
| Ethicon Endo-Surgery INC. | $11,369.89 | 2022 | |
| Medtronic, INC. | $5,822.05 | 2021-2025 | Signia |
| Astrazeneca Pharmaceuticals LP | $5,693.13 | 2024-2025 | Tagrisso |
| Davol INC. | $1,564.57 | 2021-2025 | Progel Applicator Spray Tips |
| Veran Medical Technologies, INC. | $1,376.55 | 2019 | |
| Olympus America INC. | $921.07 | 2019 | |
| On Target Laboratories, INC | $455.23 | 2024-2025 | Cytalux |
| Asensus Surgical, INC. | $447.58 | 2019 | |
| Pinnacle Biologics, INC | $274.56 | 2019 | |
| Genentech, INC. | $185.46 | 2023-2024 | Alecensa, Tecentriq |
| Noah Medical Corporation | $162.04 | 2024 | Galaxy |
| Abbott Laboratories | $147.64 | 2024 | Epic |
| Boston Scientific Corporation | $131.87 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Auris Health, INC. | $110.83 | 2019 | |
| Ethicon US, LLC | $86.00 | 2019 | |
| Atricure, INC. | $59.40 | 2022-2024 | |
| Becton, Dickinson and Company | $51.53 | 2019 | |
| Erbe USA INC | $50.00 | 2025 | Cryo2 |
| Covidien LP | $40.68 | 2019 | |
| Galvanize Therapeutics, INC | $34.37 | 2025 | Aliya System |
| Arthrex, INC. | $28.40 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.